EU watchdog aims for speedy approval of remdesivir as COVID-19 treatment

EU watchdog aims for speedy approval of remdesivir as COVID-19 treatment

Reuters

Published

The European health regulator said on Monday it would look to fast-track the approval of Gilead Sciences Inc's antiviral remdesivir as a potential COVID-19 treatment in Europe after the U.S. drugmaker submitted its marketing application.

Full Article